Mirella Marino received the M.D. degree at La Sapienza University, Rome, Italy, after training in cell biology/myogenesis in culture during medical school. In 1983, as a Fellow of the Deutsches Akademisches Austauschdienst (DAAD), she was involved in a research program led by Professor H. K. Mueller‐Hermelink on thymic epithelial tumors (TET) at the Pathologisches Institut of the Kiel University, Germany. She has been performing general surgical pathology as a Staff Pathologist first at the Hospital of S. Giacomo, Rome, and later at the Regina Elena National Cancer Institute, Rome, Italy. She was the coauthor of the “European histogenetic thymoma classification” (1985), contributed to the 2004 WHO TET classification, and is contributing to the upcoming new (2015) WHO TET classification. She is an author or coauthor of 26 papers in international journals, most of them in thymic tumors. Marino participates at the International Thymic Malignancy Interest Group (ITMIG) activities and is a Member of the Staging and Prognostic Factors Committee of the International Association Study Lung Cancer (IASLC), Thymic Domain (SPFC‐TD) (2011), and IASLC. She was granted by the Italian Ministry of Health in the framework of Italy‐US program for rare disease for research in TET. She participated in multicenter/multidisciplinary collaborative research projects on TET on a national basis based on immunohistochemistry, molecular genetics, and molecular biology and collaborated with international networks/biobanks active in TET study.
Biography Updated on 14 April 2014